Stockreport

NeurAxis Receives New FDA 510(K) Clearance for IB-Stim, Expanding its Addressable Market

Neuraxis, Inc.  (NRXS) 
PDF CARMEL, Ind., Nov. 04, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuro [Read more]